Drawing for EXPANDING THE POWER OF GENERICS

USPTO serial 50178941

EXPANDING THE POWER OF GENERICS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with EXPANDING THE POWER OF GENERICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Arturo Perez Guerrero

P.O. Box 9024163San Juan, PR 00902-4163United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of digestive diseases and disorders, gynecological diseases and disorders, hormonal disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases and disorders, genitourinary diseases and disorders, immunological diseases and disorders, infectious diseases, inflammatory diseases, metabolic diseases and disorders, psychiatric disorders, musculoskeletal diseases and disorders, respiratory diseases and disorders, circulatory system diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases, glaucoma, dental and oral diseases and disorders, headaches, migraine, obesity, liver diseases and disorders, high cholesterol, high blood pressure, rheumatic diseases and disorders, excluding all of the foregoing goods for the treatment and/or management of sleep disorders, narcolepsy, cataplexy, and/or excessive daytime sleepiness EDS; Veterinary pharmaceutical preparations for the treatment of digestive diseases and disorders, gynecological diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases and disorders, genitourinary diseases and disorders, immunological diseases and disorders, infectious diseases, inflammatory diseases, metabolic diseases and disorders, musculoskeletal diseases and disorders, respiratory diseases and disorders, circulatory system diseases and disorders, viral diseases, glaucoma; Veterinary pharmaceutical preparations for the treatment of dental and oral diseases and disorders, headaches, migraine, obesity, liver diseases and disorders, high cholesterol, high blood pressure, rheumatic diseases and disorders, excluding all of the foregoing goods for the treatment and/or management of sleep disorders, narcolepsy, cataplexy, and/or excessive daytime sleepinessACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 23, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 23, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 23, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance